Enzo Biochem (ENZB) Stock Statistics & Valuation Metrics

Enzo Biochem has a market cap or net worth of $35.71M. The enterprise value is ―.

Enzo Biochem has 52,432,130 shares outstanding. The number of shares has decreased by -2.65% in one year.

Enzo Biochem’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Enzo Biochem is ―. Enzo Biochem’s PEG ratio is ―.

In the last 12 months, Enzo Biochem had revenue of ― and earned ― in profits. Earnings per share was ―.

In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.

Enzo Biochem pays an annual dividend of $0.1, resulting in a dividend yield of ―

Enzo Biochem upcoming earnings date is Oct 21, 2025, After Close (Confirmed).

Enzo Biochem as a current ratio of ―, with Debt / Equity ratio of ―

In the past 12 months, Enzo Biochem has paid ― in taxes.

Enzo Biochem EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Enzo Biochem has ― in cash and marketable securities with ― in debt, giving a net cash position of ― billion.

Gross margin is ―, with operating margin of ―, and net profit margin of ―.

The average price target for Enzo Biochem is ―, which is 11.43% higher than the current price. The consensus rating is ―